Paola Canzano

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity.

Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 17, 2023

Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study.

Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study.

Journal: Thrombosis research

Published: November 15, 2022

Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections.

Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 14, 2022

Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior.

Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior.

Journal: International journal of molecular sciences

Published: April 06, 2022

Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study.

Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study.

Journal: JACC. Basic to translational science

Published: November 09, 2021

Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients.

Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients.

Journal: Frontiers in pharmacology

Published: September 27, 2021

Alterations in platelets during SARS-CoV-2 infection.

Alterations in platelets during SARS-CoV-2 infection.

Journal: Platelets

Published: August 13, 2021

PCSK9 promotes arterial medial calcification.

PCSK9 promotes arterial medial calcification.

Journal: Atherosclerosis

Published: July 12, 2021

Letter by Brambilla et al Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report".

Letter by Brambilla et al Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report".

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 26, 2021

Letter by Brambilla et al Regarding Article, "Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia".

Letter by Brambilla et al Regarding Article, "Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia".

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: February 24, 2021

Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.

Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.

Journal: Cardiovascular research

Published: November 23, 2020

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients.

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients.

Journal: JACC. Basic to translational science

Published: November 03, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026